Literature DB >> 8450433

Corneal topography of excimer laser photorefractive keratectomy.

S D Klyce1, M K Smolek.   

Abstract

The application of the 193 nm excimer laser for keratorefractive surgery promises to deliver a higher degree of precision and predictability than traditional procedures such as radial keratotomy. The development and evaluation of keratorefractive surgery have benefited from the parallel advances made in the field of corneal topography analysis. We used the Computed Anatomy Topography Modeling System (TMS-1) to analyze a Louisiana State University (LSU) Eye Center series of patients who had photorefractive keratectomy for the treatment of myopia with the VISX Twenty/Twenty excimer laser system. The excimer ablations were characterized by a relatively uniform distribution of surface powers within the treated zone. In the few cases that exhibited marked refractive regression, corneal topography analysis showed correlative changes. With topographical analysis, centration of the ablations relative to the center of the pupil could be evaluated. Marked improvement in centration occurred in the patients of LSU Series IIB in which the procedure to locate the point on the cornea directly over the pupil's center during surgery was refined. Corneal topographical analysis provides objective measures of keratorefractive surgical results and is able to measure the precise tissue removal effect of excimer laser ablation without the uncertainties caused by measuring visual acuity alone. Our observations forecast the need for improved aids to center the laser ablations and for the development of a course of treatment to prevent post-ablation stromal remodeling.

Entities:  

Mesh:

Year:  1993        PMID: 8450433     DOI: 10.1016/s0886-3350(13)80395-1

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  1 in total

1.  Anterior and posterior corneal curvature: normal values in healthy Iranian population obtained with the Orbscan II.

Authors:  Hamid Gharaee; Mojtaba Abrishami; Mostafa Abrishami; Seyyed Mohammad Mirhosseini; Mohammad Reza Mehrabi Bahar; Pardis Eghbali
Journal:  Int Ophthalmol       Date:  2014-09-25       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.